Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chemotherapy for osteosarcoma and Ewing's sarcoma.
Saeter G, Alvegård TA, Elomaa I, Wiebe T, Björk O, Strander H, Solheim OP. Saeter G, et al. Among authors: bjork o. Acta Orthop Scand Suppl. 1997 Feb;273:120-5. doi: 10.1080/17453674.1997.11744716. Acta Orthop Scand Suppl. 1997. PMID: 9057601 Review. No abstract available.
Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders.
Smeland S, Müller C, Alvegard TA, Wiklund T, Wiebe T, Björk O, Stenwig AE, Willén H, Holmström T, Follerås G, Brosjö O, Kivioja A, Jonsson K, Monge O, Saeter G. Smeland S, et al. Among authors: bjork o. Eur J Cancer. 2003 Mar;39(4):488-94. doi: 10.1016/s0959-8049(02)00747-5. Eur J Cancer. 2003. PMID: 12751380
Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
Schmiegelow K, Al-Modhwahi I, Andersen MK, Behrendtz M, Forestier E, Hasle H, Heyman M, Kristinsson J, Nersting J, Nygaard R, Svendsen AL, Vettenranta K, Weinshilboum R; Nordic Society for Paediatric Haematology and Oncology. Schmiegelow K, et al. Blood. 2009 Jun 11;113(24):6077-84. doi: 10.1182/blood-2008-11-187880. Epub 2009 Feb 17. Blood. 2009. PMID: 19224761 Free PMC article.
Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia.
Schmiegelow K, Björk O, Glomstein A, Gustafsson G, Keiding N, Kristinsson J, Mäkipernaa A, Rosthøj S, Szumlanski C, Sørensen TM, Weinshilboum R. Schmiegelow K, et al. Among authors: bjork o. J Clin Oncol. 2003 Apr 1;21(7):1332-9. doi: 10.1200/JCO.2003.04.039. J Clin Oncol. 2003. PMID: 12663723 Clinical Trial.
Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia. Nordic Society for Pediatric Hematology and Oncology (NOPHO).
Schmiegelow K, Glomstein A, Kristinsson J, Salmi T, Schrøder H, Björk O. Schmiegelow K, et al. Among authors: bjork o. J Pediatr Hematol Oncol. 1997 Mar-Apr;19(2):102-9. doi: 10.1097/00043426-199703000-00002. J Pediatr Hematol Oncol. 1997. PMID: 9149738
Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
Márky I, Björk O, Forestier E, Jónsson OG, Perkkiö M, Schmiegelow K, Storm-Mathiesen I, Gustafsson G; Nordic Society of Pediatric Hematology and Oncology. Márky I, et al. Among authors: bjork o. J Pediatr Hematol Oncol. 2004 Sep;26(9):555-60. J Pediatr Hematol Oncol. 2004. PMID: 15342981
Intensive Chemotherapy Without Radiotherapy Gives More than 85% Event-Free Survival for Non-Hodgkin Lymphoma Without Central Nervous Involvement: A 6-Year Population-Based Study From the Nordic Society of Pediatric Hematology and Oncology.
Márky I, Björk O, Forestier E, Jónsson ÓG, Perkkiö M, Schmiegelow K, Storm-Mathiesen I, Gustafsson G. Márky I, et al. Among authors: bjork o. J Pediatr Hematol Oncol. 2004 Sep;26(9):555-560. doi: 10.1097/01.mph.0000139772.98685.d2. J Pediatr Hematol Oncol. 2004. PMID: 27811620
69 results